题名 | An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury |
作者 | |
发表日期 | 2020-09 |
发表期刊 | JOURNAL OF PHARMACY AND PHARMACOLOGY 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | icariin icariin liposome liposome muscle injury |
其他关键词 | ISCHEMIA/REPERFUSION INJURY ; SKELETAL-MUSCLE ; IN-VITRO ; PHARMACOKINETICS ; ATHEROSCLEROSIS ; REGENERATION ; EPIMEDIUM ; RECOVERY ; COLLAGEN ; RATS |
摘要 | Objectives Icariin, extracted from Epimedium, is a kind of flavonoid and possesses osteogenesis and antioxidant. This study aimed to evaluate the therapeutic effects of icariin liposome on acute blunt skeletal muscle injury in rats. Methods Icariin liposome was prepared by the thin-film dispersion method. After muscle injury, the corresponding treatment measures were given every day for two weeks. Recovery and mechanism of muscle injury were evaluated by QRT-PCR, HE, immunohistochemistry, malondialdehyde, superoxide dismutase and serological tests. Key findings The particle size, polydispersity index, zeta potential, encapsulation efficiency and drug loading of icariin liposomes were 171.37 +/- 38.23 nm, 0.27 +/- 0.01, -5.59 +/- 1.36 mV, 78.15 +/- 2.04% and 15.62%, respectively. The QRT-PCR showed that icariin liposome significantly promoted the expression of MHCIIB and vimentin. Through HE, immunohistochemistry, ELISA and serological tests, we found that icariin liposome effectively promoted desmin expression, reduced collagen I expression and inhibited the production of pro-inflammatory factors, including TNF-alpha and IL-6. Icariin liposome therapy significantly reduced the level of malondialdehyde and increased the activity of superoxide dismutase. Conclusions Icariin liposome has excellent therapeutic effects on acute blunt muscle injury in rats by improving immunity, repairing cytoskeleton and cellular integrity, anti-inflammation, anti-fibrosis and antioxidant stress. |
资助项目 | National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701928]; Zhejiang Medical and Health Science and Technology Plan Project [2017KY480] |
出版者 | WILEY |
出版地 | HOBOKEN |
ISSN | 0022-3573 |
EISSN | 2042-7158 |
卷号 | 72期号:9页码:1152-1164 |
DOI | 10.1111/jphp.13314 |
页数 | 13 |
WOS类目 | Pharmacology & Pharmacy |
WOS研究方向 | Pharmacology & Pharmacy |
WOS记录号 | WOS:000541540900001 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 32567690 |
SCOPUSEID | 2-s2.0-85087315580 |
通讯作者地址 | [Cai, Leyi]Department of Orthopaedics,Wenzhou Medical University Second Affiliated Hospital,Wenzhou,China ; [Cai, Leyi]Wenzhou Medical University,Wenzhou,China |
Scopus学科分类 | Medicine (all) |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/1541 |
专题 | 附属第二医院 温州医科大学 |
通讯作者 | Cai, Leyi |
作者单位 | 1.Department of Orthopaedics,Wenzhou Medical University Second Affiliated Hospital,Wenzhou,China; 2.Wenzhou Medical University,Wenzhou,China |
第一作者单位 | 附属第二医院; 温州医科大学 |
通讯作者单位 | 附属第二医院; 温州医科大学 |
第一作者的第一单位 | 附属第二医院 |
推荐引用方式 GB/T 7714 | Wang, Jinwu,Zhu, Gaosheng,Wang, Xingyu,et al. An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY,2020,72(9):1152-1164. |
APA | Wang, Jinwu., Zhu, Gaosheng., Wang, Xingyu., Cai, Jie., Xie, Linzhen., ... & Cai, Leyi. (2020). An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury. JOURNAL OF PHARMACY AND PHARMACOLOGY, 72(9), 1152-1164. |
MLA | Wang, Jinwu,et al."An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury".JOURNAL OF PHARMACY AND PHARMACOLOGY 72.9(2020):1152-1164. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论